主动脉血管支架市场规模、份额和成长分析(按产品、最终用户和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1896011

主动脉血管支架市场规模、份额和成长分析(按产品、最终用户和地区划分)—产业预测(2026-2033 年)

Aortic Stent Grafts Market Size, Share, and Growth Analysis, By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End User (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球主动脉血管支架市场规模预计在 2024 年达到 33.5 亿美元,从 2025 年的 35.1 亿美元成长到 2033 年的 50.6 亿美元,在预测期(2026-2033 年)内复合年增长率为 4.7%。

全球主动脉血管支架市场正经历显着成长,主要受主动脉瘤发生率上升和心血管疾病日益增多的推动。患者越来越倾向于选择血管内治疗而非传统开放性手术,这得益于微创手术带来的更快康復和更少不适感,从而推动了胸主动脉瘤和腹部主动脉血管瘤修復的需求。都市化加快、研发投入增加以及医疗基础设施改善均对市场动态正面影响。然而,一些挑战,例如对新型血管内修復术(EVAR)的认知度较低、内漏等併发症风险以及某些地区熟练医务人员短缺等,可能会阻碍市场扩张。儘管有这些挑战,血管支架设计的创新进展仍为市场相关人员提供了充满希望的机会。

全球主动脉血管支架市场驱动因素

由于几个关键因素,全球主动脉血管支架市场预计将迎来显着成长。其中,患者越来越倾向于选择血管内修復而非传统开放性手术是主要影响因素,其次是预期寿命的延长和微创手术的普及。此外,旨在提升此类医疗设备性能的临床试验数量显着增加,以及创新型主动脉血管支架设计获得监管部门核准,这些因素共同促成了积极的市场前景,并推动了技术和治疗方案的进步,从而造福患者。

限制全球主动脉血管支架市场的因素

全球主动脉血管支架市场的发展面临许多重大挑战。合格医疗专业人员的严重短缺阻碍了这些器械的有效应用。此外,医疗专业人员对最新血管内动脉瘤修復术(EVAR)技术的训练不足,也导致他们不愿意采用新的治疗方法。再者,对潜在併发症(例如内漏和其他与主动脉血管支架手术相关的不利事件)的担忧,也可能使医疗服务提供者和患者望而却步。这些因素迭加在一起,有可能限制市场的扩张及其全部潜力的发挥。

全球主动脉血管支架市场趋势

受人口老化、主动脉瘤发生率上升以及医疗技术进步等多种因素的影响,全球主动脉血管支架市场呈现稳定上升的趋势。心臟病负担日益加重,促使医疗机构寻求有效的治疗方案,从而推动了对创新血管支架物产品的需求。此外,监管核准流程的日益高效,也促进了新技术进入市场。消费者对支架和移植物器械的益处和选择的认知不断提高,也进一步推动了市场发展,预计这将在不久的将来推动市场实现显着增长和发展。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球主动脉血管支架市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 腹主动脉血管支架
  • 胸主动脉血管支架

全球主动脉血管支架市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 医院
  • 门诊手术中心

全球主动脉血管支架市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Medtronic(Ireland)
  • WL Gore & Associates, Inc.(USA)
  • Cook Medical(USA)
  • Terumo Aortic(Japan)
  • Endologix LLC(USA)
  • Jotec(Germany)
  • MicroPort Scientific Corporation(China)
  • Corcym(Italy)
  • Edwards Lifesciences Corporation(USA)
  • Bentley Healthcare Pvt. Ltd.(India)
  • Braile Biomedica(Brazil)
  • Cardinal Health(USA)
  • InSitu Technologies Inc.(USA)
  • Artivion Inc.(USA)
  • Cryolife Inc.(USA)
  • Lombard Medical Inc.(UK)
  • Bolton Medical(Spain)

结论与建议

简介目录
Product Code: SQMIG35B2078

Global Aortic Stent Grafts Market size was valued at USD 3.35 Billion in 2024 and is poised to grow from USD 3.51 Billion in 2025 to USD 5.06 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global aortic stent graft market is witnessing significant growth driven by the increasing prevalence of aortic aneurysms and rising cardiovascular diseases. As patients lean towards endovascular repair over traditional open surgeries, the demand for thoracic and abdominal aneurysm repairs grows, fueled further by the preference for minimally invasive procedures that promise quicker recovery and less discomfort. Urbanization, increased research and development efforts, and improvements in healthcare infrastructure contribute positively to market dynamics. However, challenges such as limited awareness regarding new EVAR treatments, the potential risk of complications like endoleaks, and a shortage of skilled healthcare professionals in certain regions could impede market expansion. Despite these challenges, innovative advancements in stent graft designs present promising opportunities for market players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Stent Grafts Market Segments Analysis

Global Aortic Stent Grafts Market is segmented by Product, End User and region. Based on Product, the market is segmented into Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Stent Grafts Market

The global aortic stent grafts market is expected to experience significant growth driven by several key factors. The rising preference for endovascular repair techniques over traditional open surgeries is a major influence, alongside an increase in life expectancy and the growing trend toward minimally invasive surgical procedures. Additionally, there is a notable rise in the number of clinical trials aimed at enhancing these medical devices, coupled with the approval of innovative aortic stent graft designs by regulatory authorities. Collectively, these elements contribute to a positive outlook for the market, fostering advancements in technology and treatment options for patients.

Restraints in the Global Aortic Stent Grafts Market

The growth of the Global Aortic Stent Grafts market faces several significant challenges. A notable shortfall in appropriately skilled healthcare professionals hinders the effective implementation of these devices. Additionally, insufficient training regarding the latest endovascular aneurysm repair (EVAR) techniques contributes to reluctance among practitioners to adopt new treatments. Furthermore, concerns surrounding potential complications, such as endoleaks and other adverse effects associated with aortic stent graft procedures, may deter both healthcare providers and patients. This combination of factors could limit the market's ability to expand and fully realize its potential.

Market Trends of the Global Aortic Stent Grafts Market

The Global Aortic Stent Grafts market is witnessing a robust upward trend, driven by various factors including an aging population, escalating rates of aortic aneurysms, and advancements in medical technology. The increasing burden of cardiac disorders is prompting healthcare providers to seek effective treatment solutions, thereby enhancing demand for innovative stent graft products. Additionally, regulatory approvals are becoming more streamlined, facilitating quicker market entry for new technologies. Heightened consumer awareness regarding the benefits and options available in stent and graft devices further underscores the market's momentum, positioning it for significant growth and development in the foreseeable future.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Aortic Stent Grafts Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

Global Aortic Stent Grafts Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers

Global Aortic Stent Grafts Market Size & CAGR (2026-2033)

  • North America (Product, End User)
    • US
    • Canada
  • Europe (Product, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Aortic (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corcym (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley Healthcare Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braile Biomedica (Brazil)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InSitu Technologies Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artivion Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryolife Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lombard Medical Inc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bolton Medical (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations